Cell Point
Centennial, US · Delaware LLC
Biotech
Founders & leadership
JB
Jerry BryantNamed on SEC filing
FD
Frank David RolloNamed on SEC filing
TA
Terry Allen ColipNamed on SEC filing
GR
Greg Russell ColipNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$12.8M disclosed across 2 of 5 rounds · 2011–2021
▶$3.8MofferedJun 2021 · BiotechnologyRule 506(b)
▶$3.8MofferedJun 2021 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jerry BryantExecutive Officer
- Greg ColipExecutive Officer
- Terry ColipExecutive Officer
- Offering amount
- $3.8M
- Minimum investment
- $50K
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$10.6MraisedJun 2021 · 151 investors · BiotechnologyRule 506(b)
▶$10.6MraisedJun 2021 · 151 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Greg Russel ColipExecutive Officer
- Terry Allen ColipExecutive Officer
- Jerry BryantExecutive Officer
- Offering amount
- $33.4M
- Amount sold
- $10.6M
- Minimum investment
- $25K
- Proceeds to insiders
- $2.3M
- First sale
- Jan 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$5MofferedOct 2018 · BiotechnologyRule 506(b)
▶$5MofferedOct 2018 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jerry BryantExecutive Officer
- Offering amount
- $5M
- Minimum investment
- $50K
- Finders' fees
- $100K
- Proceeds to insiders
- $150K
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$19.4MofferedMar 2014 · BiotechnologyRule 506(b)
▶$19.4MofferedMar 2014 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Greg Russel ColipExecutive Officer
- Frank David RolloExecutive Officer
- Terry Allen ColipExecutive Officer
- Jerry BryantExecutive Officer
- Offering amount
- $19.4M
- Minimum investment
- $50K
- Sales commissions
- $1.9M
- Proceeds to insiders
- $400K
- Placement agents
- R.W. Pressprich
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedFeb 2012 · 6 investors · BiotechnologyRule 506(b)
▶$2.2MraisedFeb 2012 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Frank David RolloExecutive Officer
- Terry Allen ColipExecutive Officer
- Jerry BryantExecutive Officer
- Greg Russell ColipExecutive Officer
- Offering amount
- $5M
- Amount sold
- $2.2M
- Minimum investment
- $30K
- Sales commissions
- $5.1K
- First sale
- Mar 2011
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cell Point raised?
- Cell Point has disclosed $12.8M raised across 2 of its 5 known rounds.
- Where is Cell Point headquartered?
- Cell Point is headquartered in Centennial, US.